KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Bio-Rad Laboratories (BIO) EPS (Basic) (2016 - 2026)

Bio-Rad Laboratories has reported EPS (Basic) over the past 18 years, most recently at -$19.55 for Q1 2026.

  • Quarterly EPS (Basic) fell 953.71% to -$19.55 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $5.83 through Mar 2026, up 107.65% year-over-year, with the annual reading at $27.87 for FY2025, 142.64% up from the prior year.
  • EPS (Basic) was -$19.55 for Q1 2026 at Bio-Rad Laboratories, down from $26.41 in the prior quarter.
  • Over five years, EPS (Basic) peaked at $27.89 in Q4 2022 and troughed at -$112.5 in Q1 2022.
  • The 5-year median for EPS (Basic) is $2.29 (2025), against an average of -$11.73.
  • Year-over-year, EPS (Basic) soared 540.27% in 2024 and then plummeted 953.71% in 2026.
  • A 5-year view of EPS (Basic) shows it stood at $27.89 in 2022, then plummeted by 56.44% to $12.15 in 2023, then plummeted by 310.45% to -$25.57 in 2024, then soared by 203.29% to $26.41 in 2025, then plummeted by 174.02% to -$19.55 in 2026.
  • Per Business Quant, the three most recent readings for BIO's EPS (Basic) are -$19.55 (Q1 2026), $26.41 (Q4 2025), and -$12.7 (Q3 2025).